Connection

James Ballenger to Substance Withdrawal Syndrome

Back to Details
This is a "connection" page, showing publications James Ballenger has written about Substance Withdrawal Syndrome.
James Ballenger
Connection Strength
0.717
Substance Withdrawal Syndrome
  1. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
    View in: PubMed
    Score: 0.164
  2. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict. 2001; 10(s1):s16-s23.
    View in: PubMed
    Score: 0.141
  3. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period. Alcohol Clin Exp Res. 1999 Jun; 23(6):1077-84.
    View in: PubMed
    Score: 0.126
  4. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993 Oct; 54 Suppl:15-21; discussion 22-4.
    View in: PubMed
    Score: 0.085
  5. Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry. 1991 Jan; 52(1):39-40.
    View in: PubMed
    Score: 0.070
  6. Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull. 1984; 20(3):572-84.
    View in: PubMed
    Score: 0.043
  7. Medication discontinuation in panic disorder. J Clin Psychiatry. 1992 Mar; 53 Suppl:26-31.
    View in: PubMed
    Score: 0.019
  8. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder. Adv Biochem Psychopharmacol. 1992; 47:431-47.
    View in: PubMed
    Score: 0.019
  9. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21.
    View in: PubMed
    Score: 0.016
  10. Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71.
    View in: PubMed
    Score: 0.012
  11. Carbamazepine in alcohol withdrawal syndromes: relationship to the kindling model. J Clin Psychopharmacol. 1983 Jun; 3(3):204-5.
    View in: PubMed
    Score: 0.010
  12. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry. 1997; 58 Suppl 11:11-8.
    View in: PubMed
    Score: 0.007
  13. Discontinuation of alprazolam after long-term treatment of panic-related disorders. J Clin Psychopharmacol. 1992 Oct; 12(5):352-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.